Shlapatska L M, Kovalevska L M, Gordiienko I M, Sidorenko S P
Laboratory of Signal Transduction Pathways, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine.
Exp Oncol. 2014 Sep;36(3):162-9.
X-linked lymphoproliferative disease type 1 (XLP1) belongs to genetically determined primary immunodeficiency syndromes with mutations in SH2D1A/DSHP/SAP gene. The dramatic increase of the risk of B-cell lymphoma development in XLP1 patients is linked not only to SAP deficiency of NK, NKT and T cells, but probably to the impairment of B cell differentiation.
To analyze the receptor-mediated Akt/PKB and ERK1/2 phosphorylation and expression of transcription factors that are involved in B cell maturation in EBV-transformed B-lymphoblastoid cell lines (B-LCLs) from XLP1 patients (XLP B-LCLs) in comparison with conventional B-LCLs.
Studies were performed on EBV-transformed XLP B-LCLs IARC 739, SC-XLP and RP-XLP in comparison with SAP-negative B-LCL T5-1 and SAP-positive B-LCL MP-1. Western blot analysis was used for evaluation of Akt (Ser473) and ERK1/2 (Thr202/Tyr204) phosphorylation in response to ligation of CD150, CD40, and IgM cell surface receptors. The expression levels of transcription factors IRF4, IRF8, BCL6, BLIMP1, SPIB, PU.1 and MITF were assessed using quantitative RT-PCR.
It was shown that SAP deficiency in XLP B-LCL did not abrogate CD150-mediated Akt and ERK1/2 phosphorylation. At the same time, ligation of CD150 or IgM affects kinetics and amplitude of ERK1/2 activation. In XLP B-LCL the CD150 signaling with IgM coligation play the dominant role in both Akt and ERK1/2 phosphorylation. We found that significantly reduced IRF4, IRF8 and PU.1 expression levels are the key features of XLP B-LCLs.
XLP B-LCLs and conventional B-LCLs have differences in kinetics and amplitude of Akt and ERK1/2 phosphorylation. Analysis of transcription factors profile revealed the distinguishing features of XLP B-LCLs with SAP deficiency that may impair B cell differentiation.Key Words: B-lymphoblastoid cell lines, X-linked lymphoproliferative disease type 1, CD150, CD40, BCR, Akt/PKB, ERK1/2, transcription factors.
X连锁淋巴增殖性疾病1型(XLP1)属于由SH2D1A/DSHP/SAP基因突变导致的遗传性原发性免疫缺陷综合征。XLP1患者发生B细胞淋巴瘤的风险显著增加,这不仅与自然杀伤细胞、自然杀伤T细胞和T细胞中SAP缺乏有关,还可能与B细胞分化受损有关。
分析XLP1患者的EB病毒转化B淋巴母细胞系(B-LCLs,XLP B-LCLs)中,与常规B-LCLs相比,受体介导的Akt/PKB和ERK1/2磷酸化以及参与B细胞成熟的转录因子的表达情况。
对EB病毒转化的XLP B-LCLs IARC 739、SC-XLP和RP-XLP进行研究,并与SAP阴性的B-LCL T5-1和SAP阳性的B-LCL MP-1进行比较。采用蛋白质免疫印迹分析评估CD150、CD40和IgM细胞表面受体连接后Akt(Ser473)和ERK1/2(Thr202/Tyr204)的磷酸化情况。使用定量逆转录聚合酶链反应评估转录因子IRF4、IRF8、BCL6、BLIMP1、SPIB、PU.1和MITF的表达水平。
结果显示,XLP B-LCL中SAP缺乏并不消除CD150介导的Akt和ERK1/2磷酸化。同时,CD150或IgM的连接会影响ERK1/2激活的动力学和幅度。在XLP B-LCL中,CD150信号与IgM共连接在Akt和ERK1/2磷酸化中起主导作用。我们发现,IRF4、IRF8和PU.1表达水平显著降低是XLP B-LCLs的关键特征。
XLP B-LCLs与常规B-LCLs在Akt和ERK1/2磷酸化的动力学和幅度上存在差异。转录因子谱分析揭示了SAP缺乏的XLP B-LCLs的显著特征,这可能会损害B细胞分化。关键词:B淋巴母细胞系;X连锁淋巴增殖性疾病1型;CD150;CD40;BCR;Akt/PKB;ERK1/2;转录因子